AI MARKET SCANNING

Arvinas, Inc.

📅 Next Catalyst: Nov 04, 2026 (☀️ Open) 🏛️ NASDAQ 📁 Healthcare 🏭 Biotechnology
AVG HISTORICAL GAP +0.06%
MAX GAP RECORD -7.89%
🔒 PRO INSTITUTIONAL AI PREDICTIVE WIN RATE
94.2%
REVEAL PRO DIRECTION ⚡

SENTINEL HISTORICAL GAP VIEWER

// $ARVN
📊 1-YEAR TIMELINE (GAPS PLOTTED) 🔮 SIMULATE SETUP 🔒
Bullish Opening Gap Bearish Opening Gap T-1 Close Baseline

CATALYSTS & GAP HISTORY

Nov 04, 2026 Earnings Release 2026-11-04 (BEFORE OPEN (07:00)) 🔮 UPCOMING 🔒
Aug 04, 2026 Earnings Release 2026-08-04 (BEFORE OPEN)
+3.35%
May 11, 2026 Earnings Release 2026-05-11 (AFTER CLOSE)
+1.76%
Feb 24, 2026 Earnings Release 2026-02-24 (BEFORE OPEN)
-7.89%
Nov 05, 2025 Earnings Release 2025-11-05 (BEFORE OPEN)
-1.15%
Aug 06, 2025 Earnings Release 2025-08-06 (BEFORE OPEN)
-6.44%
Apr 30, 2025 Earnings Release 2025-04-30 (BEFORE OPEN)
-0.96%
Feb 11, 2025 Earnings Release 2025-02-11 (BEFORE OPEN)
-1.27%

VOLATILITY & GAP BIAS

AVG GAP MOVE 2.6%
Bullish Gaps (7)
Bearish Gaps (4)
Neutral / Flat (3)

QUANTITATIVE LIVE RADAR BLOTTER

Algorithmic execution stream for $ARVN

EXECUTIONS1 LOGS
STATUS🔒 ENCRYPTED
Execution Date Strategy & Setup Direction Execution Range Hold Time Net PnL
2026-10-30 🔒 PRO RADAR ••• x• $•••.•• → $•••.•• 1131m +0.35%
🔒 Real-Time Strategy Telemetry Protected

Exact execution levels, Trailing Stops, and live bot signals are reserved for PRO members.

UNLOCK LIVE RADAR ⚡

📖 Intelligence Summary

Arvinas, Inc., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company develops proteolysis targeting chimeras (PROTAC) targeted protein degraders that are designed to harness the body's own natural protein disposal system to degrade and remove disease-causing proteins. It is also…

NEXT UPCOMING PREDICTIVE SIGNAL
STRONG BUY / TARGET +35%
🔓 REVEAL AI SIGNAL & TARGETS ↗